The culture, business customs, and health care system vary greatly among Japan, China, and South Korea. However, the desire of people to be healthy is the same. As each government moves ahead with the reform of their healthcare systems, we will contribute to medical industry by establishing various medical services suitable for each local area through collaboration with business partners.
Strengthening Healthcare Platform Functions in China
Suzuken has been developing pharmaceutical distribution operations in Shanghai and Qingdao by establishing in 2008, a joint venture (49.9% ownership), Shanghai Suzuken Huzhong Pharmaceutical Co., Ltd. (now SPH Suzuken Huzhong (Shanghai) Pharmaceutical Co., Ltd.), with Shanghai Pharmaceutical Co., Ltd., a major Chinese pharmaceutical wholesaler.
In September 2016, Suzuken acquired a 35% stake in EPS EKISHIN Co., Ltd.,*1 a member of the EPS Group. Together, the two are helping Suzuken (Shenzhen) Pharmaceutical Co., Ltd. (20% stake held by Suzuken) to introduce the products of Japanese pharmaceutical companies to the Chinese market and are performing technical sales promotion activities throughout China on behalf of Suzuken (Shenzhen) Pharmaceutical.
Working with its partners, Suzuken draws on R&D, clinical trial, manufacturing, sales, sales promotion, distribution, and collection functions to create a healthcare platform capable of providing customers with the one-stop services they need.
Looking to the future, Suzuken will continue to create new added value for the field of healthcare in China.
- ※1EPS EKISHIN Co., Ltd. is a specialized trading company connecting Japan and China in the field of healthcare. Its wide-ranging business pursuits span areas as varied as CRO services, pharmaceutical manufacturing, and sales agency for digital diagnostic imaging equipment.
Contributing to the Distribution of Pharmaceuticals and the Further Development of the Pharmaceutical Industry in South Korea
Suzuken entered into a capital and business alliance with BOKSAN NICE Co., Ltd.*2 taking a 45% stake in that company in June 2016. Drawing on knowledge it has developed in the field of health creation in Japan, the Suzuken Group is supporting BOKSAN NICE in its efforts to expand its pharmaceutical distribution business to cover all of South Korea and advance joint R&D in medical-care related businesses.
The Suzuken Group is also helping BOKSAN NICE to enhance its corporate value through joint projects for strengthening its distribution functions and management platform.
By supporting the development of BOKSAN NICE, we are also contributing to the advancement of pharmaceutical distribution and industries related to medical care in South Korea.
- ※2BOKSAN NICE Co., Ltd. with operations mainly in Busan Metropolitan City and the Seoul Capital Area, is a pharmaceutical distribution leader in South Korea.